Close

Analyst Ratings for Design Therapeutics Inc (DSGN) [Buys]

DSGN Rating Summary

DSGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on DSGN
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $6.75 (+54.8%) * Over Last 12-Mos
Rating Score: 2 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/7/2024 Piper Sandler Yasmeen Rahimi Upgrade Overweight
(Neutral)
12.00
(6.00)
3.72
(4.36)
17.2% Details